Brought to you by:
Letter to the editor: The vascular influencer
Dear editor, Reading “Likes, dislikes and reposts: The new age of the vascular surgery influencer,” by Drs. Jean Bismuth (@jeanbismuth) and Jonathan Cardella (@yalevascular), they rightly point the spotlight on the trend of some vascular surgeons posting cases on social…
Viz.ai receives FDA 510(k) clearance for abdominal aortic aneurysm AI algorithm
Viz.ai recently announced it has received Food and Drug Administration (FDA) 510(k) clearance for its algorithm intended to detect suspected abdominal aortic aneurysm (AAA). Viz AAA is the first FDA-cleared AI-powered solution for the detection and triage of suspected AAA,…
ABCs for the treatment of lower-extremity acute DVTs
Ashish Gupta, MD, outlines his ABCs for confronting and treating patients with acute deep vein thrombosis (DVT) of the lower extremity, and how he developed his dictums. A is for “anticoagulation” for not more than six months of duration. Rationale:…
From the SVS president: Supporting one another
The Society for Vascular Surgery (SVS) has a vision that is unwavering. We desire quality vascular care for all patients by providing our members with the information and tools they need to provide best care. We believe the goal is…
SCVS 2023: Four decades of AAAs in the US: Rare epidemiological study establishes women are diagnosed and repaired 10 years later than men
Abdominal aortic aneurysm (AAA) diagnosis and repair occurs among women almost 10 years later than in men—with similar age-adjusted mortality—the 2023 Society for Clinical Vascular Surgery (SCVS) annual meeting in Miami (March 25–29) is set to be told. The finding…
Vesteck completes first-in-human use of several Suture-Tight devices
Vesteck scientific advisory board members along with key opinion leaders from around the world have successfully completed the first three in-human cases with the Suture-Tight catheter, a press release reports. Dai Yamanouchi (University of Wisconsin, Madison, USA) and Dainis Krievins…
Shockwave Medical announces US launch of new peripheral IVL catheter
Shockwave Medical announced the full U.S. commercial availability of the Shockwave L6 peripheral intravascular lithotripsy (IVL) catheter following clearance by the Food and Drug Administration (FDA). A press release details that the Shockwave L6 catheter is purpose-built to modify calcification in otherwise difficult-to-treat…
SVS member elected to RUC committee
SVS member David Han, MD, has been re-elected to the American Medical Association (AMA) Relative Values Scale (RVS) Update Committee (RUC). Han’s two-year term runs from March 2023 and ends in February 2025. This is the third time Han will…
Corner Stitch: What I wish I had known in vascular training
Welcome newly matched vascular surgery residents into the fold! I am just over six months into my first attending position after completing my residency training at Dartmouth. While nothing reminds you of how much you don’t know or haven’t seen…
Government Grand Rounds: Culture of engagement
Welcome back to Government Grand Rounds, where the Society for Vascular Surgery (SVS) Advocacy Council discusses how sustained advocacy engagement is important for all SVS members. While “advocacy” continues to rank high among SVS member priorities, many remain unsure how…